FAM135A and pancreatic neoplasm: The results of this current study may be the first to demonstrate the upregulation of miR-145 correlated with the downregulation of the predicted downstream target FAM135A, which was observed within the other chemoresistant cell lines and has been recently demonstrated to function in lipid metabolism within other cancers such as breast and pancreatic cancers [62,63].